Cindy Jacobs - Sep 4, 2025 Form 4 Insider Report for ACHIEVE LIFE SCIENCES, INC. (ACHV)

Role: President & CMO
Signature: /s/ Sandra Thomson as attorney-in-fact for Cindy Jacobs
Stock symbol: ACHV
Transactions as of: Sep 4, 2025
Transactions value $: -$76,532
Form type: 4
Date filed: 9/8/2025, 04:51 PM
Previous filing: Jan 30, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
JACOBS CINDY	President & CMO	22722 29TH DR SE, SUITE 100, BOTHELL	/s/ Sandra Thomson as attorney-in-fact for Cindy Jacobs	2025-09-08	0001229762

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACHV	Common Stock	Options Exercise	$0	+110K	+331.19%	$0.00	143K	Sep 4, 2025	Direct	F1
transaction	ACHV	Common Stock	Sale	-$76.5K	-27.6K	-19.29%	$2.77	116K	Sep 4, 2025	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACHV	Performance Restricted Stock Unit (PRSU)	Options Exercise	$0	-84K	-100%	$0.00	0	Sep 4, 2025	Common Stock	84K		Direct	F4, F5, F6
transaction	ACHV	Performance Restricted Stock Unit (PRSU)	Options Exercise	$0	-26K	-20%	$0.00	104K	Sep 4, 2025	Common Stock	26K		Direct	F5, F7, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.
F2	Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs.
F3	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors.
F5	Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
F6	Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.
F7	Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors.
F8	Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period.